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Objective: There is little understanding of the neural system abnormalities subserving adolescent major depres-
sive disorder (MDD). In a cross-sectional study we compare currently unipolar depressed with healthy adoles-
cents to determine if group differences in greymatter volume (GMV)were inﬂuenced by age and illness severity.
Method: Structural neuroimaging was performed on 109 adolescents with current MDD and 36 healthy controls,
matched for age, gender, and handedness. GMV differences were examined within the anterior cingulate cortex
(ACC) and across thewhole-brain. The effects of age and self-reported depressive symptomswere also examined
in regions showing signiﬁcant main or interaction effects.
Results: Whole-brain voxel based morphometry revealed no signiﬁcant group differences. At the whole-brain
level, both groups showed a main effect of age on GMV, although this effect was more pronounced in controls.
Signiﬁcant group-by-age interactions were noted: A signiﬁcant regional group-by-age interaction was observed
in the ACC. GMV in the ACC showed patterns of age-related differences that were dissimilar between adolescents
with MDD and healthy controls. GMV in the thalamus showed an opposite pattern of age-related differences in
adolescent patients compared to healthy controls. In patients, GMV in the thalamus, but not the ACC, was in-
versely related with self-reported depressive symptoms.
Conclusions: The depressed adolescent brain shows dissimilar age-related and symptom-sensitive patterns of
GMV differences compared with controls. The thalamus and ACC may comprise neural markers for detecting
these effects in youth. Further investigations therefore need to take both age and level of current symptoms
into account when disaggregating antecedent neural vulnerabilities for MDD from the effects of MDD on the de-
veloping brain.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The emergence of major depressive disorder (MDD) in adolescence
is associated with poorer lifelong health outcomes for the individual
which may, in part, be related to suboptimal brain maturational pro-
cesses (Paus et al., 2008). This observation is coupled with evidence
showing that despite remittance of depression, traces of the illness
may remain in the brain (sometimes termed neural residue) rendering
an individual more vulnerable to subsequent episodes (Kendler et al.,
2000; Post, 1992). Early detection and treatment, a therapeutic goaltry, University of Cambridge,
ind Sciences, Robinson Way,
1223336968.
. This is an open access article underfor clinicians, may serve to minimise these neural traces and therefore
reduce the neural risks accruing from depression in youth.
One strategy for further understanding the pathophysiology ofMDD
is to examine brain structural differences between affected and unaf-
fected young persons prior to treatment. Endocrine, psychological, neu-
roimaging and post-mortem examinations of MDD have implicated the
hypothalamic–pituitary–adrenal axis, cortico-striatal-pallidal-thalamic,
amygdalo-striato-pallido-thalamic, default mode, reward system,
cortico-basal ganglia circuit, orbital prefrontal and medial prefrontal
(which incorporates the fronto-limbic system) networks (Wilkinson
and Goodyer, 2011; Graham et al., 2013; Roiser et al., 2012; Gotlib
et al., 2010; Marchand and Yurgelun-Todd, 2010; Price and Drevets,
2012). While several components of these networks, including the
pre- and subgenual anterior cingulate cortex (pgACC; sgACC), have
shown reduced gray matter volume (GMV) in adults with depressionthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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that GMV reductions in the pregenual ACC are themost consistent ﬁnd-
ing across whole-brain voxel-based morphometry (VBM) studies of
MDD in adults (Bora et al., 2012). Notably, the meta-analysis failed to
ﬁnd amygdala or hippocampal regional differences in GMV in individ-
uals with MDD (Bora et al., 2012), in line with a recent large study of
adult MDD that also failed to ﬁnd group differences in limbic regions
(Grieve et al., 2013).We therefore restricted our focus to the ACC region
only.
Using a region of interest (ROI) approach and manual tracing tech-
niques, a recent study of adolescents with current depression revealed
signiﬁcantly smaller GMV in the ACC in comparison to healthy controls
(MacMaster et al., 2014). Furthermore, at trend-level signiﬁcance, GMV
reductions in the ACC differentiated MDD from bipolar disorder
(MacMaster et al., 2014). Researchers noted that male adolescents
mostly drove the effect in the ACC, despite no observable sex-
differenceswithin theMDDgroup alone (MacMaster et al., 2014). Inter-
estingly, a recent prospective longitudinal study of a community sample
of adolescents prior to and following their ﬁrst depressive episode failed
to observe a signiﬁcant main effect of group or group-by-time interac-
tions in the ACC (Whittle et al., 2014) The different results observed
across the two studies may have been attributable to the relatively
small sample size, given the heterogeneity of MDD. Thus, it is unclear
whether similar differences in brain structure can be extended to a
much larger sample of adolescents who are currently depressed.
While not much is known about the neurobiological pathophysiolo-
gy of depression in adolescence, a considerable reorganisation of grey
and white matter is known to occur in the healthy adolescent brain
(Lenroot and Giedd, 2006). Gender may play a role in adolescent brain
development as total brain volume, which encompasses grey and
white matter and cerebrospinal ﬂuid, peaks earlier for girls than for
boys, with boys, on average, possessing larger brains than girls irrespec-
tive of height and weight differences (Lenroot and Giedd, 2006). With
respect to GMV, different curvilinear patterns of development (often
described as an inverted U) may characterise the growth of different
brain regions (Grieve et al., 2013), with phylogenetically older brain re-
gions maturing at relatively younger ages than regions more recently
evolved (Lenroot and Giedd, 2006; Gogtay et al., 2004). Thus, when
identifying structural changes in thedepressed adolescent brain, studies
should account for gender and age-related changes in structural brain
development in order to minimise false positives.
To better understand the neural changes associatedwithMDD in ad-
olescence, we examined cross-sectional differences in brain structure
associated in a large sample of adolescents compared with healthy
age- and gender-matched controls. Acknowledging that ﬁrst episodes
occur prior to age 18 years in an estimated 25% of adult individuals
with mood disorders and that age (and associated neurobiological
changes) plays a key role in the aetiology of mental illness (Jones,
2013), and depression in particular (Whittle et al., 2014), we examined
differences in GMV between groups of adolescents with current depres-
sion and and healthy controls taking the putative effects of age on GMV
into account (Paus et al., 2008). Given that the most common ﬁnding in
adults withMDD is reduced GMV in pregenual ACC (Bora et al., 2012), a
region important to both the onset and course of depressive illness
(Chen et al., 2007), we predicted that adolescents with MDD would
show reduced GMV in this region relative to healthy adolescents irre-
spective of age-dependent change. We conjecture that the ACC is a sen-
sitivemarker of the neural impact of illness irrespective of the age of the
patient.
In adolescence, reduced GMV implies relative maturity in many re-
gions of the adolescent brain apart from the temporal lobes (Lenroot
and Giedd, 2006).We acknowledge, however, that adverse experiences
in early childhood are more often associated with onsets of depression
in early as opposed to late adolescence (Andersen and Teicher, 2008),
and that genetic factors aremore often associatedwith onsets of depres-
sion in late as opposed to early adolescence (Peterson et al., 2014), wespeculate that an alternate hypothesis can be tested whereby the effect
of MDD on GMVmay be inversely related to age. This hypothesis would
hold that younger aged depressed individuals are more prone to accel-
eratedmaturation of this region than their older ill counterparts. If true,
then we would predict a signiﬁcant group × age interaction with youn-
ger MDD cases showing the strongest effects of illness on the ACC.
We have previously shown a non-depressive comorbidity preva-
lence of approximately 50% for MDD patients attending UK-NHS Clinics
(Goodyer et al., 2008) with the most common comorbid diagnoses
being anxiety disorders. Furthermore a general factor of distress ap-
pears to underlie the reporting of both depressive and anxiety symp-
toms in this age range (Brodbeck et al., 2014). Consequently, we
included self-reported measures of depressive symptoms and also
trait anxiety. As researchers suggest that the neural traces of depression
may develop in proportion to the severity of each depressive episode
(Wichers et al., 2010; Robinson and Sahakian, 2008), we also tested
the hypothesis that higher self-reported symptom levelswould be asso-
ciated with greater reductions in GMV in the ACC Independent of age.
2. Materials and methods
2.1. Subject characteristics
This study, Magnetic Resonance — IMPACT (MR-IMPACT), was an
adjunct to the Improving Mood with Psychoanalytic and Cognitive
Therapies (IMPACT) clinical trial (Goodyer et al., 2011) fromwhich sub-
jects with moderate to severe depression were recruited. Full details of
theMR-IMPACT protocol are given in Hagan et al. (2013) but, brieﬂy, all
patient subjects met DSM-IV criteria for current MDD (presence of 1
core symptom and 4 additional depressive symptoms in the 2 weeks
prior to interview), as determined by combining information from
child and parent interviews using the Kiddie Schedule for Affective Dis-
orders and Schizophrenia — Present and Lifetime version (K-SADS-PL;
Kaufman et al., 1997). Self-report depression scores using the Mood
and Feelings Questionnaire (MFQ), obtained at the time of research as-
sessment for the trial reveal a mean of 45.6 (S.D. 10.5) out of a maxi-
mum possible score of 66; the index of caseness for depressions is
taken as a score of N26 (Angold et al., 1987).
General exclusion criteria for IMPACT and MR-IMPACT included the
presence of one or more of the following: alcohol or drug abuse or de-
pendence; pervasive developmental disorder or generalised learning
problems resulting in an inability to complete study questionnaires;
current and necessary use of medication with possible adverse interac-
tionswith SSRIs; presence of MRI contraindication or brain abnormality
(either known beforehand or identiﬁed by a neuroradiologist via axial
proton density T2 or axial ﬂair images); or intolerance to the MRI envi-
ronment. All participants and their families provided written informed
assent and consent, with procedures carried out in accordance with
the Declaration of Helsinki. (World Medical Association, World
Medical Association, 2008) Ethical approval for the study was granted
by the National Research Ethics Service Committee East of England –
Cambridge Central.
Table 1 presents the demographic data of theMR-IMPACT cohort. All
demographic data were analysed using version 19 of the Statistical
Packages for the Social Sciences (SPSS; IBM Corporation, New York). In-
dependent sample t-tests were performed to explore group differences
in all demographic variables, with the exception of categorical data on
which chi-square testswere performed.WhereMauchly3s test indicated
a violation of sphericity, Greenhouse–Geisser corrections were applied.
All tests were performed with levels of signiﬁcance established at
p b 0.05, two-tailed.
Considering the potential effects of clinical heterogeneity on any re-
sults, we included a substantial number of adolescents with current
DSM IV MDD (unipolar) episodes in an effort to increase power and
thus our ability to detect brain structural differences that we could in-
terpret as associated with this psychiatric syndrome. In total, 128
Table 1
Demographic and clinical characteristics of the depressed and healthy adolescent groups.
Healthy
adolescents
n = 36
Depressed
adolescents
n = 109
F or χ2 p
Mean Age (SD), range 15.65 (1.45),
12.14–17.73
15.56 (1.27),
11.83–17.96
F = 0.831 p = 0.722
% female 72.22% 74.31% χ2 = 0.061 p = 0.805
% right-handed 91.67% 87.16% χ2 = 0.532 p = 0.466
IQ (available from 22 patients and 36 controls) 100.94 (10.93) 96.59 (11.45) F = 0.615 p = 0.436
Mean SMFQ score 2.97 (1.92) 17.46 (5.07) F = 28.501 p b 0.001
Mean STAI state score 29.53 (6.45) 45.64 (10.90) F = 10.633 p b 0.001
Mean STAI trait score 31.03 (6.39) 60.37 (8.08) F = 3.225 p b 0.001
% ﬁrst MDD episode (available from 90 patients) – 93.33%
Antidepressant medication use:
Fluoxetine – 29.36%
Citalopram – 3.67%
Propanolol – 0.92%
Sertraline – 0.92%
Other medications used:
Risperidone 0 2.75%
Cetirizine 0 1.83%
Doxycycline 0 1.83%
Gabapentin 0 0.92%
Mefenamic acid 0 0.92%
Tetralysal 0 0.92%
Pizotifen 0 0.92%
Levothyroxine 0 0.92%
Prednisone 0 0.92%
Ranitidine 0 0.92%
Lamotrigine 0 0.92%
Zolpidem 0 0.92%
Circadin 0 0.92%
Diazepam 0 0.92%
Mebeverine 0 0.92%
Fenagon 0 0.92%
Inﬂiximab 0 0.92%
Mesren 0 0.92%
Azathioprine 0 0.92%
Asthma medication 0 1.83%
Pentasa 2.78% 0
Ibuprofen 2.78% 0
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ed to MR-IMPACT from NHS clinics in the East Anglian (n= 110) and
North London regions (n= 18) of the UK. Nineteen were excluded for
one of three reasons: 2 for brain abnormalities; 11 for brace or retaining
wire MRI artefacts; 6 for scans occurring after psychological treatment
had commenced. Thus, 109 adolescents with depression were included
in the overall analysis (81 female, 28 male, mean (M) age ± standard
deviation (SD) = 15.56 ± 1.27, age range = 11.83–17.96). On
average females were older (M = 15.68, SD = 1.14) than males
(M = 15.22, SD = 1.57), however, this difference was not signiﬁcant
t(107)=−1.65, p=0.10 and represented a small sized effect r=0.16.
Approximately one third of these patients were taking antidepres-
sant medication at the time of scanning and all were randomised to
one of three possible types of active psychological treatment (specialist
clinical care, cognitive behaviour therapy, or short-term psychoanalytic
therapy). Antidepressant medication was restricted to selective seroto-
nin reuptake inhibitors (SSRIs), with ﬂuoxetine the most common pre-
scribed medication (Table 1). Of the 37 medicated subjects with
depression, 24 were female and 13 were male (M ± SD = 15.71 ±
1.35). Again, females were older on average (M = 15.92, SD = 1.18)
than were males (M = 15.33, SD = 1.61). This difference was not
signiﬁcant t(35) = −1.28, p = 0.21 and represented a small effect
size, r= 0.21.
Forty healthy young persons, matched for age, gender, and handed-
ness, were recruited from local Cambridgeshire schools by study adver-
tisement to the students and their parents. Four were excluded due to
brain abnormality, pre-existing medical condition, or brace/retaining
wire artefact, leaving 36 control subjects (26 female, 10 male, M ±
SD = 15.65 ± 1.45, age range = 12.14–17.73); see Table 1 for details.Healthy control females were, on average, older (M = 15.81, SD =
1.52) than males (M= 15.25, SD = 1.22), however, this difference was
not signiﬁcant t(34) =−1.03, p= 0.31 and represented a small effect
size, r=0.17. Control participantsmet the same inclusion criteria applied
to the depressed group, with the exception of screening for lifetime his-
tory of mood disorder or substance dependence in ﬁrst-degree relatives
or a personal history of psychopathology requiring clinical treatment.
Control participants were excluded if they had either a lifetime history
of psychopathology requiring clinical treatment, or a history in the im-
mediate family of mood disorder or substance dependence. Control par-
ticipants also were screened with the self-report Moods and Feelings
Questionnaire — Short version (SMFQ) and were required to obtain a
score≤5 which is less than the clinical cutoff of≥8 (Angold et al., 1995).
For a simple two-group comparison of means (i.e., a t-test), the
power to detect aﬁxed effect size is a function of the ratio of participants
in each group. Given the sample sizes for each group, we estimate our
power for detecting true signiﬁcant effects at 0.70.
2.2. Structural MRI (sMRI) data acquisition
MR images of all subjects were acquired by a 3.0 Tesla Magnetom
Trio Tim scanner (Siemens, Surrey, England) ﬁtted with a quadrature
birdcage head coil at the Wolfson Brain Imaging Centre, University of
Cambridge, UK. A T1-weighted image was acquired in the sagittal
plane using a three-dimensional magnetically prepared rapid acquisi-
tion gradient echo sequence (3D-MPRAGE; 176 slices of 1.00mm thick-
ness, echo time = 2.98 ms, repetition time = 2.30 s, inversion time =
900 ms, ﬂip angle = 9°, ﬁeld of view = 240 × 256 mm2, voxel size =
1.0 × 1.0 × 1.0 mm3, series = interleaved).
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echo — proton density and T2-weighted sequence by a senior
neuroradiologist.2.3. Pre-processing and statistical analysis of sMRI data
Whole brain VBMwas ﬁrst used to identify pre-treatment anatomi-
cal differences between patients and controls. Voxelwise estimates of
GMV from each participant3s T1-weighted images were calculated
using an optimised VBM protocol (Good et al., 2001) using version 5
of FSLVBM (Smith et al., 2004); http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
FSLVBM) from the Functional Magnetic Resonance Imaging of the
Brian software library (FSL; Douaud et al., 2007).
Structural imageswere ﬁrst skull-stripped using the brain extraction
tool (Smith, 2002) and then segmented into grey and white matter tis-
sue types using FAST (Zhang et al., 2001). Grey matter partial volume
images from a subset of 72 subjects (36 subjects from each group,
matched for age, gender and handedness) were used to generate a
study speciﬁc template against which all remaining native grey matter
partial volume images were subsequently non-linearly re-registered.
Grey matter partial volume images from the subset of subjects were
ﬁrst aligned to Montreal Neurological Institute (MNI) standard space
using the afﬁne linear registration tool FLIRT (Jenkinson and Smith,
2001; Jenkinson et al., 2002) followed by non-linear registration using
FNIRT (Andersson et al., 2007). The resulting images were processed
to create a left–right symmetric, study-speciﬁc grey matter template.
All native space grey and white matter images were then non-linearly
registered to the respective study-speciﬁc greymatter andwhitematter
template and modulated to control for local expansion or contraction.
The modulated GMV images were then smoothed with an isotropic
Gaussian kernel with a sigma of 3 mm.2.3.1. Statistical analysis of sMRI data
2.3.1.1. Whole brain voxel-based analysis. Gender wasmodelled as a nui-
sance covariate. We opted against modelling either total intracranial
volume (TIV) or total GMVas a nuisance covariate as it is strongly collin-
ear with age in adolescence due to brain maturation.
Voxelwise main effects of group, age and group-by-age interactions
were examined by regression of the general linearmodel (GLM). Signif-
icant clusters were identiﬁed using threshold-free cluster enhancement
(Smith and Nichols, 2009) with the threshold for signiﬁcance set at
p b 0.05, Family-Wise Error (FWE) correction for multiple comparisons
for both whole-brain analysis and in small volumes (i.e., small volume
correction, SVC; Friston, 1997; Worsley et al., 1996). The Harvard–Ox-
ford neuroanatomical Atlas was used to label statistically signiﬁcant
clusters (http://neuro.debian.net/pkgs/fsl-harvard-oxford-cortical-
lateralized-atlas.html). Clusters smaller than 20 voxels are not reported.
For regions showing group-by-age interactions, estimates of mean
tissue volumes were extracted to visualise the effect.2.3.2. Small volume correction analysis within ACC
The ACC was deﬁned as an ROI given the consistency with which
structural differences are observed in this region in a meta-analysis of
studies of adult MDD (Bora et al., 2012). The ACC was anatomically de-
ﬁned using the atlas for automated anatomical labelling (AAL; (Tzourio-
Mazoyer et al., 2002)) within MRICro (http://www.mccauslandcenter.
sc.edu/mricro/). Within the AAL atlas, templates for “Cingulum_Ant_R”
and “Cingulum_Ant_L”were combined to delineate a bilateral ACC ROI.
Voxelwisemain effects of group, age, and group-by-age interactions
were examined using the same procedures described above. Threshold-
free cluster enhancement correction for multiple comparisons was ap-
plied within the ACC mask and the level of signiﬁcance set at p b 0.05
FWE corrected.2.4. Post-hoc tests
For regions showing a signiﬁcant main effect of group or group-by-
age interaction, values were extracted to conduct partial correlations
with GMV, controlling for age and gender, ﬁrst across the entire cohort
and then within each group separately. These tests were conducted to
examine the nature of the relationship between any volumetric differ-
ences observed, irrespective of age and gender, either across the
whole cohort or within each group alone.Within regions showing a sig-
niﬁcant relationship with group, age, or group-by-age interaction,
values were extracted to conduct within-group linear regressions inde-
pendentlywith SMFQ and STAI-T in theMDD group only, controlling for
the confounding inﬂuence of gender and age. These tests were conduct-
ed to ascertain the inﬂuence of severity of depression or anxiety onGMV
irrespective of patient sex or age.
3. Results
3.1. Group differences in the ACC
Prior to running analyses, the effect of medication was examined
within the depressed group only. No effect of medication was observed
in the ACC. Furthermore, medication use was not observed to show an
interaction with either gender or age (or age covarying for gender) in
the ACC. A decision was therefore made to combine the medicated
and unmedicated depressed groups into a singleMDD group for all sub-
sequent analyses detailed below.
3.1.1. Main effect of group
No signiﬁcant main effect of group was observed in the pregenual
region of the ACC (Table S1 available online).
3.1.2. Main effect of age
There was a signiﬁcant negative relationship between GMV and age
in the left paracingulate gyrus (Fig. 1, Table S1, available online).
3.1.3. Group-by-age interaction
A signiﬁcant group-by-age interactionwas observed in ACC and con-
ﬁned to the pregenual region. The region showing a group-by-age inter-
action did not overlap with the region showing a main effect of age.
Depressed adolescents showed no signiﬁcant change in GMV with age
in this region whereas the healthy adolescents showed a reduction
(Fig. 2, Table S1, available online).
3.2. Group differences across the whole-brain
Prior to running analyses, the effect of medication was examined
within the depressed group only. No effect of medication was observed
at the level of the whole-brain. Furthermore, medication use was not
observed to show an interaction with either gender or age (or age co-
varying for gender) in any region across the whole-brain. A decision
was therefore made to combine the medicated and unmedicated de-
pressed groups into a single MDD group for all subsequent analyses de-
tailed below.
3.2.1. Main effect of group
No signiﬁcant main effect of group was observed in GMV across the
whole-brain (Table S1, available online).
3.2.2. Main effect of age
No signiﬁcant positive relationship with age was observed in GMV
across the whole-brain. However, a signiﬁcant negative relationship
with age was observed in several grey matter regions including the
right orbital frontal cortex extending to the pgACC (Fig. 3, Table S1,
available online). Other regions showing a signiﬁcant negative relation-
ship with age are reported in Table S1, available online.
Fig. 1. Regions showing age-related decreases in GMV for both groups in the ACC, covarying for gender and associated partial regression plot with 95% conﬁdence intervals. The values
shown on x- and y-axes respectively represent residualised age and residualised average GMV.
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A signiﬁcant group-by-age interaction was observed in the thala-
mus. Depressed adolescents showed a mean reduction in GMV with
age in this region whereas the healthy adolescents showed a mean in-
crease with age (Fig. 4, Table S1, available online). The region showing
a group-by-age interaction did not overlap with any region showing a
main effect of age.Fig. 2. The group-by-age interaction in the ACC (A). Partial regression plot showing the betwe
respectively represent residualised age and residualised average GMV (B). Post-hoc within-gro
The values shown on x- and y-axes respectively represent residualised depression scores and res
GMV in the ACC region and severity of depression (r=−0.03, p= 0.77) (C). Each plot also in3.3. Post-hoc correlations
3.3.1. GMV
Controlling for age and gender, partial correlations with GMV were
examined in regions showing a signiﬁcant group-by-age interaction
(i.e., ACC and thalamus), ﬁrst across the entire cohort and then within
each group separately. When controlling for gender and age, GMV inen-group relationship with age, covarying for gender. The values shown on x- and y-axes
up partial regression with self-reported depression severity, covarying for age and gender.
idualised averageGMV. AdolescentswithMDD showed no signiﬁcant correlation between
cludes 95% conﬁdence intervals.
Fig. 3.Regions showing age-relateddecreases inGMV for both groups across thewhole brain, covarying for gender and associatedpartial regression plotwith 95% conﬁdence intervals. The
values shown on x- and y-axes respectively represent residualised age and residualised average GMV.
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thewhole cohort (r=−0.20, p=0.02), however, were not signiﬁcant-
ly correlatedwhen looking at either group alone (MDD: r=−0.07. p=
0.50; Control: r=−0.19, p= 0.28).
3.3.2. Severity of symptoms
Correlations with symptom severity were examined in regions
showing a signiﬁcant group-by-age interaction (i.e., ACC and thalamus)Fig. 4.The group-by-age interaction in the thalamus (A). Partial regression plot showing the betw
respectively represent residualised age and residualised average GMV (B). Post-hocwithin-grou
ing for age and gender. The values shown on x- and y-axes respectively represent residualised
icant within-group negative correlation between GMV in the thalamus and self-reported depre
intervals.using partial linear regression in the depressed group only controlling
for age and gender.3.3.3. Anterior cingulate cortex
Adolescents with MDD showed no signiﬁcant correlation between
GMV in the ACC region and severity of depression (r = −0.03, p =
0.77) (Fig. 2). Furthermore GMV in that region did not signiﬁcantlyeen-group relationshipwith age, covarying for gender. The values shownon x- and y-axes
p partial regressionwith self-reported depression severity in the depressed group, covary-
depression scores and residualised average GMV. Adolescents with MDD showed a signif-
ssive symptoms (SMFQ r=−0.21, p= 0.03) (C). Each plot also includes 95% conﬁdence
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able online).
3.3.4. Thalamus
Adolescents with MDD showed a signiﬁcant within-group negative
correlation between GMV in the thalamus and self-reported depressive
symptoms (SMFQ r=−0.21, p=0.03; Fig. 4). A signiﬁcantnegative cor-
relation with level of trait anxiety was also observed (STAI-T r=−0.23,
p= 0.02) (Fig. S2, available online).
4. Discussion
Our hypothesis that MDD patients would show signiﬁcant reduc-
tions in GMV in the ACC compared with controls was not supported.
This null result was obtained despite, to our knowledge, this being the
largest group of adolescents with current MDD studied to date. The al-
ternate hypothesis that there would be an effect of age on group differ-
ences was supported. Thus relative to age-matched healthy controls,
younger patients with current depression show a dissimilar pattern of
GMV differences across agemeans compared to older patients with cur-
rent depression in the ACC (see Fig. 2B). We cautiously interpret these
cross-sectional data as suggesting that in depression, age may index a
set of latent factors that are operating differentially in the younger
more immature and older maturing adolescent brain, although further
longitudinal research is required to ﬁrmly attest to such a claim. The
ACC in depressed adolescents may therefore be age-sensitive and have
prognostic effects. The presence of an interaction giving opposite effects
by age are very likely accounting for the absence of an overall group dif-
ference between adolescents with current depression and healthy con-
trols. Interestingly, post-hoc testing in theMDDgroup indicated that the
group-by-age interaction in pgACC was unrelated to current self-
reported symptoms (see Fig. 2C). This suggests that age rather than sub-
jective severity of illnessmay be a better index ofGMVdifferences in the
depressed adolescent brain.
In contrast, and unexpectedly, we showed that adolescent patients
with current MDD compared to healthy controls also show an interac-
tion between age-related differences in GMV in the thalamus. While
the cross-sectional nature of the data render it difﬁcult to know the
true direction of these differences, adolescents with depression show
an opposing pattern of GMV changes with age relative to healthy con-
trols (see Fig. 4B). The presence of signiﬁcant within-group correlations
between GMV in the thalamus and self-reported depressive symptoms
supports the possibility of an effect of depressive severity on this region
in adolescentswith currentMDD (see Fig. 4C).When controlling for age
and gender, GMV in thalamic and ACC regions showing a signiﬁcant
group-by-age interaction did not correlate with one another in the
MDD group alone, suggesting that in adolescence these regions may
be related to different aspects of the illness. Given the vast clinical het-
erogeneity of the disorder, larger samples examining subtypes of MDD
mayprovemore fruitful. Indeed, the presence of a signiﬁcant correlation
between thalamic and ACC GMV across the entire cohort of adolescents
suggests that larger samples may be needed when examining correla-
tions between regions showing different relationships between GMV
and age.
The location of the results in theACCwas similar to those reported in
depressed adults (Bora et al., 2012). Here, only the pregenual region of
the ACC showed signiﬁcant GMV interactions between group and age,
with controls showing a dissimilar pattern of GMV differences across
age compared to depressed patients. While the signiﬁcance of this dis-
similarity is unclear, one potential explanation is that MDD is preferen-
tially occurring in the presence of a more mature ACC, particularly in
early adolescence. Other possible explanations are that adolescents
with MDD have delayed or abnormal brain development relative to
healthy controls and do not show the normative pattern of GMV reduc-
tion in the ACC over time. Again however as these results are cross-
sectional, longitudinal replication is needed in order to accuratelychart the developmental trajectory of the ACC in adolescents with and
without MDD. Contrary to the structural imaging literature in adult
MDD (Bora et al., 2012) small volume correction of the ACC was neces-
sary to detect differences in case–control relationships with age in
this region, suggesting that observable (at the whole-brain level)
between-group VBM differences emerge over time after symptoms
emerge. This explanation is in line with the failure of Whittle and
colleagues (Whittle et al., 2014) to observe signiﬁcant group-by-time
interactions in a community sample of adolescents prior to and follow-
ing their ﬁrst depressive episode. GMV in the pgACCwas not signiﬁcant-
ly correlated with either severity of current depression or level of trait
anxiety, perhaps attributable to the relative stability of GMV in this re-
gion across age in the MDD group.
4.1. The thalamus as a locus of adolescent MDD
The signiﬁcant post-hoc correlation between self-reported severity
of depression and anxiety and thalamic reductions in GMV in the
MDD group (see Fig. 4C) suggests that, in adolescence, volumetric re-
ductions of thalamic grey matter are associated with the quality of the
MDD episode. Volumetric differences in the thalamus are not common-
ly reported in structural studies of adults with MDD (Bora et al., 2012),
yet a recent study on a large cohort of adultswith currentMDD reported
volumetric reductions in bilateral thalamus (Nugent et al., 2013). Post-
mortem studies show an elevated neuronal density in the mediodorsal
nucleus of patients with MDD, but not in healthy subjects or subjects
with bipolar disorder or schizophrenia (Young et al., 2004). The
thalamus has been suggested to undergo a signiﬁcant amount of
reorganisation fromearly childhood through adolescence to early adult-
hood (Lebel et al., 2008). Thus, in adolescents with MDD the change in
GMVwith agemay reﬂect reorganisation of this region rendering detec-
tion of group differences in GMV difﬁcult. Despite the paucity of re-
search showing volumetric differences in the thalamus, there is good
evidence for the persistence of functional changes in the thalamus asso-
ciated with adult MDD (Graham et al., 2013; Hamilton et al., 2012).
While the coarse spatial resolution of whole-brain structural neuroim-
aging precludes localisation of our results to thalamic nuclei or a single
nucleus of the thalamus, pulvinar and medio-dorsal nuclei are spatially
consistent with the result observed.
4.2. The emergence of GMV deﬁcits in the anterior cingulate
In contrast to the unanticipated ﬁndings in the thalamus, MDD ado-
lescents showed a pattern of age-related differences in GMV in the
pgACC distinct to healthy controls (see Fig. 2B), as expected from
large-scale studies of normal brainmaturation (Paus, 2005). Other stud-
ies of adolescents with depression have failed to ﬁnd signiﬁcant group-
by-time interactions in ACC (Whittle et al., 2014), but thismay be attrib-
utable to the comparatively smaller sample size of adolescent patients.
Given the vast clinical heterogeneity in MDD, large numbers of patients
may be necessary before signiﬁcant group differences can be observed.
The pgACC is a component of both the fronto-limbic systemand theme-
dial network within CSPT circuitry (Price and Drevets, 2012; Drevets,
2001; Mayberg, 2003; Seminowicz et al., 2004) and is suggested to
link cognitive with emotional processes (Mayberg, 1997). Unlike in
adults (Bora et al., 2012), adolescents with MDD do not display group
differences in GMV in pgACC relative to healthy adolescents (cf.
Whittle et al., 2014), suggesting that the aberrant links between cogni-
tive and emotional processes in depression emerge over time. The rela-
tively stagnant pattern of GMV with age in pgACC (see blue line in
Fig. 2B) may also explain the absence of a relationship between GMV
and symptoms of either depression or anxiety in this region.
Despite total brain volume (encompassing grey matter, white mat-
ter and cerebrospinal ﬂuid) remaining constant across adolescence
(Lebel et al., 2008), different patterns of brain development occur in dif-
ferent regions of the brain and thesematurational changes coupledwith
398 C.C. Hagan et al. / NeuroImage: Clinical 7 (2015) 391–399individual differences in neurodevelopment may also hinder the detec-
tion of group differences in brain structure between cases and controls
during this time period (Andersen et al., 2008). For example, the
medio-dorsal nucleus of the thalamus is strongly interconnected with
the ACC (Klein et al., 2010) and is associated with an accelerated rate
of change in fractional anisotropy relative to the cingulate (Lebel et al.,
2008) in adolescence. An implication from the current ﬁndings
could be that the effects on the thalamus, by adult life, inﬂuence
interconnecting regions including the pgACC.
5. Conclusions and study limitations
In conclusion, MDD patients do not show signiﬁcant reductions in
GMV in the ACC comparedwith healthy controls, contrary to our prima-
ry hypotheses. This null ﬁnding is unlikely to be attributable to insufﬁ-
cient power given the large sample of adolescents with current MDD
examined in the study. More exploratory whole-brain examinations of
the data suggest that the emergence of MDD in adolescence is associat-
ed with opposing patterns of age-related differences in the thalamus
relative to healthy adolescents (see Fig. 4B). GMV in our a priori regions
of interest, the pgACC, also showed dissimilar patterns of age-related
differences for adolescents with MDD relative to healthy adolescents
(see Fig. 2B). We propose that disruption to these regions is linked (ei-
ther consequentially or in the exacerbation of prepotent differences) to
a cascade of further dysfunction to CSPT and fronto-limbic circuits
thereby altering the course of healthy brain development. We also
show that, irrespective of gender and age, illness severity is correlated
with volume reductions in the thalamus (see Fig. 4C), a relationship
not observed in the pgACC in adolescence (see Fig. 2C). One beneﬁt of
studyingMDD during this developmental window is that it permits ex-
amination of the disorder nearer the onset with fewer confounding in-
ﬂuences, thereby providing better clues into its aetiology.
Strengths aside, our study is not without limitations. First and fore-
most, the cross-sectional nature of our data do not permit the examina-
tion or comparison of developmental trajectories across groups.
Nonetheless, we believe that cross-sectional studies can be both useful
and informative, especially with respect to providing the foundation of
information where speciﬁc hypotheses can be generated and tested in
future longitudinal research. Second, onsets of depression have been
hypothetically linked to time-sensitive disruption of regionally-
speciﬁc brain maturational cascades (Andersen and Teicher, 2008). Al-
though approximately 93% of the adolescent patients with depression
included in this sample were experiencing their ﬁrst episode, we lack
reliable information about the onset timing of depressive illness in
caseswhere the current episode is not the ﬁrst episode and thus are un-
able to examine the effect MDD onset on brain maturational processes
as was done in a recent seminal study (Whittle et al., 2014). We also
lack information with respect to timing of patient stressors and quality
of rearing environment, which limits our ability to test respective hy-
potheses of a neurodevelopmental cascade and/or psychosocial acceler-
ation (where unstable rearing environments accelerate development;
Belsky and Pluess, 2013) underlying depression in adolescence. Age in
this cross-sectional cohortmay therefore constitute a proxymechanism
for examining the moderating and mediating inﬂuences of genetic and
epigenetic vulnerability. For example, exposure to early adversity
could accelerate onsets of MDD and help to differentiate early-
from mid-to-late-adolescence onsets of MDD (Andersen and Teicher,
2008). Under this purview, adolescence would constitute a critical
neurodevelopmental period for the emergence of unipolar depressions
exposed to suboptimal family environments and result in a differential
course for these illnesses through its effects on the developing brain
and mind (Kuyken and Dalgleish, 2011; Walsh et al., 2012). Third, ap-
proximately one third of our patient sample had been takingmedication
prior to the scan. Combined with the knowledge that at least ﬁve ado-
lescent patients with MDD were experiencing a recurrent form of de-
pression at the time of scanning, and that we lacked ﬁrst episodeversus recurrent data from 14 patients, the possibility remains that
the heterogeneity of our sample precluded the observation of group dif-
ferences in GMV or weakened any results observed. Finally, we chose
not to correct for either TIV or total GMV in this developmental sample,
given that systematic cross-sectional or longitudinal studies of such cor-
rection have not been performed in this age-range (Mills and Tamnes,
2014). Correction for TIV or total GMVmaybe suboptimal due to nonlin-
ear changes in total GMV across adolescence (Hedman et al., 2012) and
region-speciﬁcmaturational heterochronicity (Paus et al., 2008) leading
to a potential bias in results (Barnes et al., 2010). Nonetheless, it is pos-
sible that correction for TIV or total GMV (in addition to age and gender)
would have altered the observed results. Limitations notwithstanding,
future work will include longitudinal behavioural and clinical follow-
up to better understand the aetiology and developmental progression
of MDD in adolescence and to provide insight into neurobiological pre-
dictors of treatment outcome. We hope that a better understanding of
the pathophysiology of depression in adolescence will help to identify
ways to alter the natural course of illness relapse and recurrence.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2014.12.019.
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